Strand Life Sciences has announced the launch of the StrandOmics Portal, an online platform designed to assist clinicians in diagnosing rare diseases more efficiently. Additionally, the company will offer genetic testing for rare diseases at a reduced cost for patients from economically disadvantaged backgrounds.
